Sunitinib treatment promotes metastasis of drug-resistant renal cell carcinoma via TFE3 signaling pathway

por Li, Luchao, Zhao, Shuo, Liu, Zhengfang, Zhang, Nianzhao, Pang, Shuo, Liu, Jikai, Liu, Cheng, Fan, Yidong
Publicado 2021

High expression of SMYD3 indicates poor survival outcome and promotes tumour progression through an IGF-1R/AKT/E2F-1 positive feedback loop in bladder cancer

por Wang, Guoliang, Huang, Yi, Yang, Feilong, Tian, Xiaojun, Wang, Kun, Liu, Li, Fan, Yidong, Li, Xiaofeng, Li, Luchao, Shi, Benkang, Hao, Yichang, Xia, Chuanyou, Nie, Qingsheng, Xin, Yue, Shi, Zhenfeng, Ma, Lulin, Xu, Dawei, Liu, Cheng
Publicado 2020